Month: August 2019

Breakingviews TV: Knockout drug

Bristol-Myers Squibb has taken a step toward closing its deal for Celgene with the $13 bln sale of the latter’s psoriasis drug to Amgen. Richard Beales says the rich price lends credence to Bristol-Myers’ claim that Celgene was undervalued, and deservi…